Hikma Stands Firm On Supply As It Scoffs At Latest Amarin Lawsuit

Motion To Dismiss Filed; Advair Expectations Disclosed

 
• By Dean Rudge
  
Fish oil with capsules
Hikma has so far taken a Vascepa market share of around 10%-12% following market entry in November. • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products